Not Signed In -
Rituximab |
Rituxan |
Image:Rituximab.png Rituximab Systematic (IUPAC) name Chimeric murine/human monoclonal anti-CD20 antibody Identifiers CAS number 174722-31-7 ATC code L01XC02 PubChem ? DrugBank BTD00014 Chemical data Formula C6416H9874N1688O1987S44 Mol. weight 143859.7 g/mol Pharmacokinetic data Bioavailability ? Metabolism ? Half life ? Excretion ? Therapeutic considerations Pregnancy cat. ? Legal status Routes ? Rituximab, ...
Wikipedia - [full article]
Rituximab News Headlines
- Phase I/II Data Support Continued Development Of Biogen Idec's Novel Anti-Cd23 Antibody For Chronic Lymphocytic Leukemia
MedicalNewsToday - Tue, 02 Jan 2007 08:00 EST
- Study Showed Epratuzumab In Combination With Rituximab And Chemotherapy Is Safe, Tolerable, And Active In Aggressive Lymphoma
MedicalNewsToday - Tue, 05 Dec 2006 08:00 EST
- Epratuzumab And Rituximab Have Different Modes Of Action
MedicalNewsToday - Tue, 14 Nov 2006 08:00 EST
- Mayo Clinic Cancer Center Collaborating To Find New Tools To Fight Leukemia
MedicalNewsToday - Thu, 14 Dec 2006 11:00 EST
- Fighting Leukemia: Regimen Of Three Chemotherapy Drugs Shows Promise
ScienceDaily - Mon, 11 Dec 2006 04:00 EST
- Dynavax Reports Positive Phase 2a NHL Data At ASH Meeting
MedicalNewsToday - Mon, 11 Dec 2006 08:00 EST
- Rituximab Efficacy In Autoantibody Seronegative Patients
MedicalNewsToday - Thu, 16 Nov 2006 08:00 EST
- Subsequent Course Of Rituxan® Improved Outcomes In Rheumatoid Arthritis Patients Who Inadequately Responded To Tnf Antagonist Therapy
MedicalNewsToday - Thu, 23 Nov 2006 08:00 EST
- Repeat Treatment With MabThera Provides Continuous Improvement Of Quality Of Life In Rheumatoid Arthritis Patients
MedicalNewsToday - Mon, 13 Nov 2006 08:00 EST
- NICE Recommends Rituximab For The First Line Treatment Of Follicular Lymphoma, UK
MedicalNewsToday - Sat, 30 Sep 2006 08:00 EST
- FDA Approves Two New Indications For Rituxan(R) In Patients With Non-Hodgkin's Lymphoma
MedicalNewsToday - Sat, 30 Sep 2006 07:00 EST
- Positive Results From Phase II Trial Of Rituxan In Relapsing-Remitting Multiple Sclerosis
MedicalNewsToday - Sat, 02 Sep 2006 06:00 EST
- Genentech And Biogen Idec Announce Positive Results From A Phase II Trial Of Rituxan In Relapsing-Remitting Multiple Sclerosis
MedicalNewsToday - Tue, 29 Aug 2006 07:00 EST
- New Evidence Shows Rituximab Halts Damage To Joints
MedicalNewsToday - Sun, 25 Jun 2006 07:00 EST
- New Evidence Shows MabThera Inhibits Joint Damage In Patients With Rheumatoid Arthritis
MedicalNewsToday - Sun, 25 Jun 2006 06:00 EST
- New Evidence Shows MabThera Inhibits Joint Damage In Patients With Rheumatoid Arthritis
MedicalNewsToday - Sun, 25 Jun 2006 12:00 EST
- Rituxan® Plus Methotrexate Reduced Joint Damage In Rheumatoid Arthritis Patients Who Respond Inadequately To TNF Antagonist Therapies
MedicalNewsToday - Mon, 26 Jun 2006 06:00 EST
- Analysis Of Phase III Study Showed Rituxan(R) Plus Methotrexate Reduced Joint Damage In Rheumatoid Arthritis Patients Who Respond Inadequately To TNF
MedicalNewsToday - Fri, 23 Jun 2006 06:00 EST
- Pixantrone Produces High Rate (77 Percent) Of Complete Tumor Disappearance In Patients With Relapsed Indolent Non-Hodgkin's Lymphoma
MedicalNewsToday - Thu, 18 May 2006 06:00 EST
- The Promise Of A B-cell Biologic Therapy For Rheumatoid Arthritis
ScienceDaily - Fri, 28 Apr 2006 02:00 EST
- Study Shows Rituximab Effective In Treating Chronic Graft Versus Host Disease
MedicalNewsToday - Mon, 27 Mar 2006 12:00 EST
- Supplemental Biologics License Application For First-Line Use Of Rituxan In Low-Grade Or Follicular CD20-Positive B-Cell Non-Hodgkin's Lymphoma
MedicalNewsToday - Sat, 01 Apr 2006 11:00 EST
- Study To Test Drug''s Potential To Preserve Insulin Production In Newly Diagnosed Type 1 Diabetics
MedicalNewsToday - Sun, 19 Mar 2006 05:00 EST
- Testing A Drug''s Potential To Preserve Insulin Production In Newly Diagnosed Type 1 Diabetics
MedicalNewsToday - Wed, 15 Mar 2006 11:00 EST
- FDA Approves Rituxan® - The First Targeted B-Cell Therapy For Treatment Of Moderate-To-Severe Rheumatoid Arthritis
MedicalNewsToday - Sun, 05 Mar 2006 11:00 EST
- Rheumatoid Arthritis Rituxan® Significantly Improves Symptoms In Patients, Phase III Study
MedicalNewsToday - Sat, 09 Apr 2005 09:00 EST
email this page
print this page
bookmark this page
feedback on this page
